Role of Inhaled Corticosteroids in Pediatric Asthma and Virus induced wheeze
Abstract
Inhaled corticosteroids (ICS) are one of the important components of childhood asthma pharmacotherapy and a common first-line treatment. Treatment with ICS decreases asthma mortality and morbidity reduces symptoms, improves lung function, improves symptoms in childhood viral-induced wheezing and reduces the number of asthma exacerbations. This study reviews the role of ICS in childhood asthma, including their mechanism of action, clinical efficacy, safety profile, and adherence challenges. The benefits of ICS in controlling symptoms and reducing morbidity outweigh their potential risks when used appropriately in proper dosages. Strategies for optimizing ICS therapy and addressing concerns about long-term use are also discussed.
Downloads
References
2. National Institutes of Health, National Heart, Lung, and Blood Institute (2007) National asthma education and prevention program. Full report of the expert panel: guidelines for the diagnosis of asthma (EPR-3). Available at http://www.nhlbi.nih. gov/guidelines/asthma
3. Brand PL, Baraldi E, Bisgaard H et al (2008) Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J 32:1096–1110
4.Tan DJ, Walters EH, Perret JL, et al. Clinical and functional differences between early- Onset and late-onset adult asthma: a population-based Tasmanian longitudinal health study. Thorax 2016;71:981–7.
5.Trivedi M, Denton E. Asthma in children and adults—what are the differences and what can they tell us about asthma. Front Pediatr 2019;7.
6. Megalaa R, Perez GF, Kilaikode-Cheruveettara S, et al. Clinical definition of respiratory viral infections in young children and potential bronchiolitis Misclassification. J Investig Med 2018;66:46–51.
7. Johnston SL, Pattemore PK, Sanderson G et al (1995) Community study of the role of viral infections in exacerbations of asthma in 9–11 year old children. BMJ 310:1225–1229
8. McKean M, Ducharme F (2000) Inhaled steroids for episodic viral wheeze in childhood. Cochrane Database Syst Rev 2:CD001107
9. Expert Panel Working Group of the National Heart, Lung, and Blood Institute (NHLBI) administered and coordinated National Asthma Education and Prevention Program Coordinating Committee (NAEPPCC), Cloutier MM, Baptist AP, et al. 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. J Allergy Clin Immunol 2020; 146:1217.
10. NICE guideline. Asthma: diagnosis, monitoring and chronic asthma management. https://www.nice.org.uk/guidance/NG 80/chapter/Recommendations#objective-tests-for-diagnosing-asthma-in-adults-young-people-and-children-aged-5-and-over.
11.Szefler SJ. Glucocorticoid therapy for asthma: clinical pharmacology. J Allergy Clin Immunol 1991; 88:147.
12.Barnes PJ. Inhaled Corticosteroids. Pharmaceuticals (Basel) 2010; 3:514.
13.Cockcroft DW, Murdock KY. Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen- induced early asthmatic responses, late asthmatic responses and increased bronchial responsiveness to histamine. J Allergy Clin Immunol. 1987;79:734–40.
14.Gotshall RW. Exercise-induced bronchoconstriction. Drugs. 2002;62:1725–39.
15. Szefler SJ, Leung DY. Glucocorticoid-resistant asthma: pathogenesis and clinical implications for management. Eur Respir J. 1997;10:1640–7.
16. Leung DY, Bloom JW. Update on glucocorticoid action and resistance. J Allergy Clin Immunol. 2003;111:3–22.
17.Spahn JD, Szefler SJ, Surs W, Doherty DE, Nimmagadda SR, Leung DY. A novel action of IL-13: induction of diminished monocyte glucocorticoid receptor-binding affinity. J Immunol. 1996;157:2654–9.
18.Buhl R. Local oropharyngeal side effects of inhaled corticosteroids in patients with asthma. Allergy. 2006;61:518-26.
19. Roland NJ, Bhalla RK, Earis J. The local side effects of inhaled corticosteroids: current understanding and review of the literature. Chest. 2004;126:213–9.
20. Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med. 1995;332:868–75.
21.Dahl R. Systemic side effects of inhaled corticosteroids in patients with asthma. Respir Med. 2006;100:1307–17.
22. The use of inhaled corticosteroids in pediatric asthma: update. Hossny et al. World Allergy Organization Journal (2016) 9:26.DOI 10.1186/s40413-016-0117-0
23. uptodate.com/contents/asthma-in-children-younger-than-12-years-overview-of-initiating-therapy-and-monitoring-control.Gregory Sawicki, accessed on 2/3/2025
24. https://www.nhlbi.nih.gov/health-topics/asthma-management-guidelines-2020-updates. accessed on 2/3/2025
25. https://www.pcrs-uk.org/resource/current/good-building-blocks-asthma-review assessed on 6/2/2025
26.https://www.derbyshiremedicinesmanagement.nhs.uk/assets/Clinical_Guidelines/Formulary_by_BNF_chapter_prescribing_guidelines/BNF_chapter_3/Childrens_Asthma assessed on 4/2/2025
27. The Role of Corticosteroids in the Management of Childhood Asthma. Peter P van Asperen. The Thoracic Society of Australia and New Zealand. https://pubmed.ncbi.nlm.nih.gov/11913918/
28. van Aalderen, W.M.C., Sprikkelman, A.B. Inhaled corticosteroids in childhood asthma: the story continues. Eur J Pediatr 170, 709–718 (2011). https://doi.org/10.1007/s00431-010-1319

Copyright (c) 2025 Author (s). Published by Siddharth Health Research and Social Welfare Society

This work is licensed under a Creative Commons Attribution 4.0 International License.